NIH Call for Global Cancer Research Abstracts
The 5th Annual Symposium on Global Cancer Research, sponsored by the National Cancer Institute (NCI), the Consortium of Universities for Global Health (CUGH), and academic partners, will be held on April 6, 2017, prior to the start of the 8th Annual CUGH Global Health Conference. The Symposium is an annual event started in 2013 that aims to promote the exchange of scientific findings, best practices, and innovations in global cancer research and control. In addition, Symposium participants work to identify potential geographic and scientific areas for collaboration and develop strategic priorities related to cancer research in low- and middle-income countries. Highly interactive discussions will cover a range of topics, foster network building, and be geared toward developing action items for advancing global cancer research and control. The Symposium consistently draws senior- and junior-level professionals from multiple sectors, providing a valuable combination of experience, enthusiasm, and varied perspectives to the discussions.
Presentation of cutting-edge research and programs that address the global burden of cancer is at the heart of the Symposium. NCI invites all persons wishing to report original research, innovative projects, or novel programs related to global cancer research and control to submit abstracts to be considered for posters and publication in the Journal of Global Oncology. Abstracts will be reviewed based on criteria that include intellectual merit, clarity, and relevance to global cancer research and control.
Abstracts will be collected through two categories: (1) Scientific – original research, or (2) Program – innovative projects that move the field forward.
- All abstracts must be submitted in English.
- Abstracts must be submitted online.
- One abstract per person as presenting author may be submitted. (Note: There is a maximum of 3 abstracts total per author)
- Abstract maximum word count is 2,500 characters, including spaces (approximately 300 words).
- Scientific abstracts must include sections with the headlines: background, aims, methods, results, and significance.
- Program abstracts must include sections with the headlines: background, goals, methods, outcomes, and next steps.
- Abstract titles must be 250 characters or less and should not be submitted in all caps.
Travel Awards: NCI intends to sponsor up to 4 travel awards that are competitively awarded to presenting authors of outstanding abstracts for from LMICs (as defined by the World Bank for 2016). Travel awards will cover airfare, hotel for two nights, and a per diem for meals and incidentals. Travel award decisions will be primarily based on reviewer rankings of the abstracts and alignment with the Symposium program. Participants who accept a travel award will be required to give an oral presentation of their work at the Symposium.
Abstract Submission Deadline: December 2, 2016, 11:59pm EST
Notification of Abstract Acceptance/Rejection and Travel Awards: January 2, 2017
Symposium Date and Venue: April 6, 2017 (all day) at the National Institutes of Health, Bethesda, Maryland
Contact: Ankur Garg, email@example.com
Winship is pleased to announce the third round of funding opportunities in the Winship Invest$ program, a peer-reviewed program designed to provide pilot funding for novel, innovative cancer research projects. Winship Invest$ will support pilot projects and enable Winship investigators to obtain preliminary data and results for publication and for peer-reviewed funding applications. Winship Invest$ will have two funding opportunities every year. Funded applications will be supported by philanthropic contributions to Winship and by developmental funds in Winship's Cancer Center Support Grant (CCSG). Proposals with a budget of up to $50,000 for one year may be considered for Winship Invest$ (unless otherwise stated for specific research domains).
Research Domains (see RFP for complete details)
Investigators may submit only one proposal per Winship Invest$ Request for Pilot Grant Proposals (RFP) cycle and identify within which research domain they seek consideration. The current Winship Invests RFP seeks applications in the following areas:
- Investigator Initiated Clinical Trials
- Immunology and Immunotherapy
- Integrative Cancer Imaging
- Pediatric Cancers
- Cancer Disease Type-Specific Research in: (a) breast cancer or (b) lung cancer
Eligibility (see RFP for complete details)
- Pilot projects will be awarded to active Winship members
- Winship members will qualify for only one pilot project grant in a given year and may not submit more than one proposal through this RFP.
- Salary support for the principal investigator is not allowed except for junior faculty at the rank of Assistant Professor and below.
- All proposals must include a clear plan for subsequent extramural grant submissions as a result of the work proposed.
- Data Management - Proposals must include a plan to maintain research data in Redcap or other secure data management system (if relevant) with quality control and stored on the Emory system with back-up and potential for data sharing. Consultation for data sharing plans with the Winship Research Informatics Shared Resource is recommended.
- Clinical Research proposals can only be submitted by MDs, MD/PhDs, or RN/PhDs and must include all required elements described in the RFP
- Proposals which include in vivo studies must include (a) a section addressing Vertebrate Animals research, and (b) IACUC protocol
- Members receiving funding are expected to submit annual progress reports to the Winship Executive Committee. Specific instructions on due dates of reports are provided at the time of funding.
Letter of Intent and Application Process
Letters of Intent (not to exceed 2 pages) are due December 9 via email to firstname.lastname@example.org. Letters of Intent should identify the PI, all potential collaborators on the project, the research domain for which the project is to be considered, a proposed title for the research project, and a brief description of the proposed research project.
Letter of Intent Deadline: December 9, 2016
Application Deadline: January 20, 2017
Anticipated Start Date: March 1, 2017
Contact: Jeff Mills, (404) 727-3634, email@example.com
Keck Foundation Research Grants
The Keck Foundation Research Program seeks to benefit humanity by supporting projects in two research areas— (1) medical research and (2) science and engineering research—that are distinctive and novel in their approach, question the prevailing paradigm, or have the potential to break open new territory in their field. Both Senior and Early Career investigators are encouraged to apply.
Keck is most interested in projects that:
- will be transformative across multiple fields, with the possibility of founding a new field of research or new ways of looking at an intractable problem;
- are “great leap” projects with the potential to develop breakthrough technologies, instrumentation, or methodologies;
- focus on important and emerging areas of research;
- are innovative, distinctive and interdisciplinary;
- demonstrate a high level of risk due to unconventional approaches, or by challenging the prevailing paradigm; and
- fall outside the mission of federal agencies and that demonstrate Keck Foundation support is essential to the project’s success.
ONE-PAGE Abstract Requirements
Please submit ONE-PAGE Abstracts to Lucy Grantham at firstname.lastname@example.org no later than December 16, 2016. In one page only (in 12-point font with 1 inch margins), with a highly trained but lay audience in mind, include the following:
- abstract/overview of the research proposed emphasizing any unique aspects;
- mention of pilot studies or data, if any – including unpublished findings – that support the idea;
- brief description of the key personnel and methodologies;
- brief justification of the particular need for Keck’s support; and
- estimated budget broken down, if possible, by major areas, e.g., personnel, equipment, consumable supplies, etc. (Budgets can be rough approximations at this stage.)
Abstract Internal Deadline: December 16, 2016
Internal Committee Review: Keck Review Committee will select a maximum of 8 abstracts
Phase I Proposal Due to Keck Foundation: May 1, 2017
Phase II: If invited to move forward applicants will be notified by Keck on July 15, 2017 with the Phase II Proposal due on August 15, 2017.
Contact: Lucy Grantham
Director of Development, Emory University
Emory University Research Committee Awards
The University Research Committee at Emory University announces the call for proposals for the 2017-2018 funding cycle of regular URC and URC-ACTSI (Atlanta Clinical & Translational Science Institute) grants. This is the only award cycle for the 2017-2018 academic year.
Applications are welcome from all regular, full-time Emory faculty, regardless of rank. The criteria for assessing applications is as follows:
- Academic, scholarly, or creative merit of the project.
- Feasibility of completing the project during the grant period.
- Significance of project to applicant’s career as well as the applicant’s potential or demonstrated productivity. Normally, preference will be given to less established researchers who, by virtue of their career stage, have less access to other sources of funding and a longer time horizon for future productivity.
- For all applicants in areas of research where extramural funding sources exist, the likelihood that University Research Committee support will eventually lead to extramural funding for the proposed work.
- If the applicant/s have received prior University Research Committee funding, they will need to supply evidence that these projects were successful in terms of extramural funding and/or peer-reviewed publications.
The online application, eligibility requirements, and criteria for submission may be accessed via the University Research Committee website (http://urc.emory.edu).
Application Deadline: 5:00pm, January 6, 2017
Contact: Terri Whitehead, (404) 712-1340 or email@example.com